BioInsights - Cell therapy CMC and quality control - spotlight

CELL & GENE THERAPY INSIGHTS

Cell therapy CMC and quality control

Christiane Niederlaender

Guest Editor:

Christiane Niederlaender, Vice President Technical at Parexel

May 2021

Download full spotlight

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

S Snykers,

A Moore,

T Kheir

26 September 2021

Expert Roundtable Video

Watch now
Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

S Snykers,

A Moore,

T Kheir

25 September 2021

Expert Roundtable

Read more
Characterization of a novel high-throughput, high-speed and high-precision plate-based image cytometric cell counting method

J Bell,

Y Huang,

H Qazi et al.

14 May 2021

Research Article

Read more
Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

L Pierce,

S Sarkar,

L Chan et al.

13 May 2021

Commentary

Read more
Bioprocess and analytics priorities for the tissue engineered product and cell therapy fields

J Allickson

13 May 2021

Interview

Read more
Unleashing the full power of next gen bioanalytics on cell therapy development

E Alonzo

13 May 2021

Interview

Read more
The role of big data analytics in digitized manufacturing

D Marshall,

J Churchwell,

M Baradez

12 May 2021

Expert Insight

Read more
Addressing sampling challenges in early phase cell therapy manufacturing

S Mgebroff

12 May 2021

Expert Insight

Read more
Cell therapy CMC and quality control

C Niederlaender

12 May 2021

Foreword

Read more
Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

V Jimenez Sabinina,

D Hildebrand

12 May 2021

Commentary

Read more